Reassessment of Omalizumab-Dosing Strategies and Pharmacodynamics in Inner-City Children and Adolescents
Year: 2013
Type: article
Institutions: University of Wisconsin–Madison, Rho (United States), Boston University, Lurie Children's Hospital, Case Western Reserve University, The University of Texas Southwestern Medical Center, Columbia University, University of Arizona, Children's National, National Institute of Allergy and Infectious Diseases, National Jewish Health, University of Colorado Anschutz, University of Colorado Denver
Language: English
Subfield: Physiology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: Amgen, AstraZeneca, GlaxoSmithKline, University of Wisconsin-Madison, National Institutes of Health, Genentech, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Center for Research Resources, National Center for Advancing Translational Sciences
Awards: G1009511856, G1330469136, Statistical and Clinical Coordinating Center for Immunologic Approaches to Reduce Asthma in Children, G1702152793, G2002785430, Clinical and Translational Science Award, G3507050984, G3608269516, Clinical and Translational Science Institute at Children's National, G4115395081, General Clinical Research Center, G4239343409, General Clinical Research Center, North and Central Texas Clinical and Translational Science Initiative (UL1), General Clinical Research Center, UT-Southwestern Clinical and Translational Alliance for Research (UT-STAR) (TL1), INNER-CITY ASTHMA CONSORTIUM, Boston University Clinical and Translational Science Award (CTSA) Program UL1, G7012968443, G7509006555, G9000205441, G9000328944, Colorado Clinical and Translational Science Institute (UL1)
OpenAlex ID: W2048725737